🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, risking fines, prosecution or prison.

Service Response and Content Elimination

According to TikTok, the platform has removed violative material and prohibited associated hashtags and query recommendations. The organization said it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Digital Marketplace Activities

Research also discovered communities with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, populated with images of weight loss, positive reviews and step-by-step guides for mixing or administering at residence.

Within moments of joining one community, a seller shared contact information, where the majority of purchases take place. The vendor provided an guidebook and promised delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Item Details and Costs

Inside these groups, messages display dark colored packages with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has previously seen individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially significant health risks”.